文献速递临床试验与 GCP基础与转化研究

全身应用甲硝唑和阿莫西林治疗重度牙周炎理想时机的随机对照试验研究方案

The ideal time of systemic metronidazole and amoxicillin administration in the treatment of severe periodontitis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-03-27

该随机对照试验旨在比较全身应用甲硝唑(MTZ)和阿莫西林(AMX)在不同阶段辅助SRP治疗重度牙周炎的临床、微生物和免疫效果。180例重度牙周炎患者随机分为三组:仅SRP组、SRP同时开始用药组和SRP完成后3个月开始用药组。主要结局为治疗后1年达到临床终点(探诊深度≥5mm的位点≤4个)的受试者数量。

要点

  • 比较MTZ+AMX在SRP治疗不同阶段给药的疗效。
  • 主要结局为1年时达到临床终点的受试者数量。
  • 每组60例,共180例重度牙周炎患者。

核心结论

  • 该研究将比较全身MTZ+AMX在SRP不同阶段给药的临床、微生物和免疫效果。

研究设计与样本

  • 随机对照试验,纳入180例重度牙周炎受试者,随机分为三组(每组60例):仅SRP组、SRP同时开始用药组和SRP完成后3个月开始用药组。
  • 所有受试者在基线、3、6和12个月接受临床和微生物评估,在基线和治疗后12个月接受免疫评估。

关键数值与推荐

  • 主要结局变量为治疗后1年达到临床终点(探诊深度≥5mm的位点≤4个)的受试者数量。
  • 微生物学分析:每受试者采集9份龈下生物膜样本,通过棋盘DNA-DNA杂交分析40种细菌的计数和比例。
  • 免疫学分析:每受试者采集6份龈沟液样本,通过多重免疫分析检测20种趋化因子水平。
  • 统计学分析采用方差分析、协方差分析、卡方检验和Tukey检验,微生物和免疫分析进行多重比较校正,显著性水平设为5%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The combination of systemic metronidazole (MTZ) and amoxicillin (AMX) with scaling and root planing (SRP) has shown to be an effective periodontal treatment. However, some essential issues associated with the use of these antibiotics remain unanswered, such as the ideal time of administration during the course of periodontal treatment. Although these agents are often prescribed after the healing phase of the SRP procedure, there is biological plausibility to support its use in conjunction with the mechanical treatment. However, to date, no placebo controlled randomized clinical trial (RCT) has directly compared these two protocols. Therefore, the aim of this RCT is to compare the clinical, microbiological and immunological effects of the adjunctive systemic MTZ + AMX administered in different phases of the treatment of severe periodontitis. METHODS: Subjects with severe periodontitis (n = 180) are being randomly assigned into three groups (n = 60/group): (i) SRP-only (control group), SRP in combination with 400 mg MTZ + 500 mg AMX, starting (ii) at the first SRP session (active phase group), or (iii) after 3 months of its completion (healing phase group). All volunteers are receiving clinical and microbiological evaluation at baseline, 3, 6 and 12 months, and immunological assessment at baseline and 12 months post-therapy. Nine subgingival biofilm samples are being collected per subject and analyzed for counts and proportions of 40 bacterial species by checkerboard DNA-DNA hybridization, and six gingival crevicular fluid samples are being collected and analyzed for the levels of 20 chemokines by multiplex immunoassay. The primary outcome variable is the number of volunteers reaching the clinical endpoint for treatment (≤ 4 sites with probing depth ≥5 mm) at 1 year post-therapy. Differences in clinical, microbiological and immunological parameters among groups and over time will be evaluated using analysis of variance, analysis of covariance and the Chi-square and Tukey tests. Microbiological and immunological analyses will be performed using adjustments for multiple comparisons. Statistical significance will be set at 5%. TRIAL REGISTRATION: ClinicalTrials.gov , NCT02954393 . Registered on 3 November 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Feres M, Retamal-Valdes B, Mestnik MJ, et al. The ideal time of systemic metronidazole and amoxicillin administration in the treatment of severe periodontitis: study protocol for a randomized controlled trial. Trials. 2018. PMID: 29587808. doi:10.1186/s13063-018-2540-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。